rivaroxaban
Showing 76 - 100 of 153
COVID-19 Trial in Austria (Chloroquine or Hydroxychloroquine, Lopinavir/Ritonavir, Best standard of care)
Unknown status
- COVID-19
- Chloroquine or Hydroxychloroquine
- +11 more
-
Innsbruck, Tirol, Austria
- +8 more
Feb 25, 2021
Venous Thromboembolism, Menstruation Trial in Indianapolis (Apixaban, Rivaroxaban)
Recruiting
- Venous Thromboembolism
- Menstruation
- Apixaban
- Rivaroxaban
-
Indianapolis, Indiana
- +1 more
Dec 4, 2019
Left Atrial Appendage Thrombosis, Thrombi, Stroke Trial (Rivaroxaban, DAPT)
Unknown status
- Left Atrial Appendage Thrombosis
- +2 more
- Rivaroxaban
- DAPT
- (no location specified)
Oct 20, 2019
ST Segment Elevation Myocardial Infarction, Left Ventricular Thrombus Trial in Shanghai (Rivaroxaban, Vitamin K Antagonist)
Recruiting
- ST Segment Elevation Myocardial Infarction
- Left Ventricular Thrombus
- Rivaroxaban
- Vitamin K Antagonist
-
Shanghai, Shanghai, ChinaRen Ji Hospital Affliated to School of Medicine, Shanghai Jiao T
Mar 11, 2020
Atrial Fibrillation, Stroke Trial in Worldwide (Rivaroxaban, Acetylsalicylic acid)
Recruiting
- Atrial Fibrillation
- Stroke
- Rivaroxaban
- Acetylsalicylic acid
-
Canberra, Australian Capital Territory, Australia
- +54 more
Mar 23, 2022
Study to Explore OAC Treatment in Korea
Completed
- Atrial Fibrillation
- Apixaban
- +4 more
-
Seoul, Korea, Republic ofKorea University Hospital
Feb 10, 2020
Atrial Fibrillation Trial in Germany (CE-mark approved LAA closure devices, Acetylsalicylic acid, Clopidogrel)
Recruiting
- Atrial Fibrillation
- CE-mark approved LAA closure devices
- +8 more
-
Berlin, Germany
- +25 more
Jul 29, 2021
Aortic Valve Stenosis, Cardiovascular Diseases, Heart Valve Diseases Trial in Worldwide (Acetylsalicylic acid, Clopidogrel,
Completed
- Aortic Valve Stenosis
- +4 more
- Acetylsalicylic acid
- +2 more
-
Los Angeles, California
- +24 more
Jan 9, 2020
Permanent Atrial Fibrillation, Venous Thrombosis, Pulmonary Embolism Trial in Angers (Rivaroxaban, Fluindione, Warfarin)
Completed
- Permanent Atrial Fibrillation
- +3 more
- Rivaroxaban
- +2 more
-
Angers, FranceUniversity Hospital Angers
Nov 5, 2019
Coronavirus, Severe Acute Respiratory Syndrome Trial in Worldwide (Colchicine, Interferon-Beta, Aspirin)
Active, not recruiting
- Coronavirus
- Severe Acute Respiratory Syndrome
- Colchicine
- +3 more
-
Manaus, Amazonas, Brazil
- +65 more
Mar 14, 2022
Atrial Fibrillation, Left Atrial Appendage Thrombosis, Rivaroxaban Trial (Rivaroxaban, Warfarin)
Unknown status
- Atrial Fibrillation
- +2 more
- Rivaroxaban
- Warfarin
- (no location specified)
Mar 18, 2019
Deep Venous Thrombosis Trial in Fredrikstad (Rivaroxaban)
Completed
- Deep Venous Thrombosis
- Rivaroxaban
-
Fredrikstad, Ostfold, NorwayOstfold Hospital Trust
Jan 18, 2019
Intracranial Hemorrhages, Intracranial Hemorrhage, Hypertensive, Subarachnoid Hemorrhage Trial in United Kingdom (Apixaban,
Completed
- Intracranial Hemorrhages
- +8 more
- Apixaban
- +6 more
-
Edinburgh, Midlothian, United Kingdom
- +66 more
Mar 31, 2022
Cancer-associated Thrombosis, Esophageal Cancer, Stomach Cancer Trial in Seoul (Rivaroxaban, Dalteparin, apixaban)
Unknown status
- Cancer-associated Thrombosis
- +9 more
- Rivaroxaban
- +2 more
-
Seoul, Korea, Republic ofAsan Medical Center
Jan 2, 2020
Vascular Calcification Trial in Aalst (rivaroxaban, Vitamin K2)
Completed
- Vascular Calcification
- rivaroxaban
- Vitamin K2
-
Aalst, BelgiumOLV Hospital
Jan 25, 2019
Acute Heart Failure Trial in Seoul (Rivaroxaban, Warfarin + LMWH)
Unknown status
- Acute Heart Failure
- Rivaroxaban
- Warfarin + LMWH
-
Seoul, Korea, Republic ofDivision of Cardiology, Severance Cardiovascular Hospital, Yonse
Jan 9, 2019
Atrial Fibrillation, Intracerebral Hemorrhage Trial in Germany, Spain, United Kingdom (Apixaban Oral Tablet, Dabigatran,
Recruiting
- Atrial Fibrillation
- Intracerebral Hemorrhage
- Apixaban Oral Tablet
- +3 more
-
Altenburg, Germany
- +27 more
Feb 17, 2021
Cerebral Venous Thrombosis Trial in Isfahan (Rivaroxaban, Warfarin)
Unknown status
- Cerebral Venous Thrombosis
- Rivaroxaban
- Warfarin
-
Isfahan, Iran, Islamic Republic ofAlzahra University Hospital
Nov 17, 2018
Portal Vein Thrombosis, Mesenteric Vein Thrombosis, Splenic Vein Thrombosis Trial in Canada, Italy (rivaroxaban)
Unknown status
- Portal Vein Thrombosis
- +2 more
- rivaroxaban
-
Hamilton, Canada
- +3 more
Nov 24, 2018
Stroke Prevention In Atrial Fibrillation (Spaf)
Completed
- Atrial Fibrillation
- apixaban
- +3 more
-
Barcelona, Cataluña, SpainIDIAP Jordi Gol
Jan 15, 2019
Medical Need of OAC Reversal
Completed
- Atrial Fibrillation
- warfarin
- +4 more
-
Tokyo, JapanNippon Boehringer Ingelheim Co., Ltd.
Oct 31, 2018
Deep Vein Thrombosis Trial in Italy (rivaroxaban, Placebo)
Unknown status
- Deep Vein Thrombosis
- rivaroxaban
- Placebo
-
Faenza, Italy
- +6 more
Nov 24, 2018